1 Existing Share To Split In 5 New Shares: Multibagger Pharma Gets New Security Codes Before 1:5 Stock Split

Ahead of the ex-split, Remedium Lifecare has announced that it received a new securities code from CDSL and NSDL due to its share split in the ratio of 1:5. This means that 1 existing equity share of Remedium will be sub-divided into five new years.

Remedium is a multi-bagger with growth of a whopping 1,851.52% from its 52-week low of Rs 35.31 apiece. Remedium's 52-week high is at Rs 898.30 apiece.

On February 19, the company touched a 20% upper circuit at Rs 700.10 per share, before ending at Rs 689.10 apiece, up by 18.11% on BSE. Its market cap is at Rs 1,389.23 Cr.

In its regulatory filing on Monday, Remedium said, "We would like to inform you that Remedium Lifecare Limited has received NEW ISIN from CDSL and NSDL pursuant to Subdivision/ Stock Split of Face Value of the Equity shares from Rs. 5/- each to Re. 11- each. Please note that the New ISIN of the Company is INE549S01036 and Subdivision/ Stock Split of Equity Shares will take effect under the New ISIN."

ISIN is important for buying or selling a stock. "ISIN" is a unique 12-digit alphanumeric code given to a security, shares, Debentures, Bonds etc. when the security is admitted into the depository system. The first two digits of the ISIN code indicate the country of registration for the security. For all securities registered on depository in India, the first two digits of the ISIN code are 'IN'.

Remedium Lifecare Stock Split:

Remedium has fixed February 23, 2024, as the record date for shares sub-division having face value of Rs 5 each to Rs 1 each. On the record date, the company will determine eligible shareholders for the latest stock split.

The purpose of the split is to enhance the liquidity in the capital market, to widen the shareholder base and to make shares affordable/accessible to retail investors in the stock market.

Earlier, last year, Remedium shares turned ex-split on September 1, 2023, for a shares sub-division to the tune of 1:2. The company's stock split in the ratio of 1:2 meant that --- one existing equity share having a face value of Rs 10 each -- was sub-divided into two equity shares having a face value of Rs 5 each.

Remedium Lifecare Bonus Share:

Remedium has also turned ex-bonus in the ratio of 9:5. Last year, the company issued nine bonus equity shares having a face value of Rs 10 each against every existing five equity shares having a face value of Rs 5 per share.

Remedium Lifecare Dividend:

Remedium has not declared any dividends yet.

About Remedium Lifecare:

Remedium Lifecare which was earlier incorporated as Roxy Engineers, is now engaged in the trading of pharmaceutical products and various raw materials used in the pharmaceutical industry including but not limited to Aminoisophthalic Acid, Tellurium(IV) Oxide, Grignard Reagent, Iodine, Selenium Metal Powder, Trimethyl Solfoxonum Iode(TMSI). With the Remedium Lifecare entered the Bombay Stock Exchange (BSE). The stock trades under the small-cap basket.

Disclaimer: The write-up highlights about the latest development in stock split, and is not a recommendation to buy, sell or hold. We have not done fundamental or technical analysis and have no opinion on the stock mentioned. Neither, the author nor Greynium Information Technologies should be held liable for any losses. Please consult a professional advisor.